Engimmune Therapeutics raises CHF 15.5 million in seed financing to develop novel T-cell receptor therapeutics | DNA RNA and Cells

Engimmune Therapeutics raises CHF 15.5 million in seed financing to develop novel T-cell receptor therapeutics

Related Keywords

Zurich ,Züsz ,Switzerland ,Denmark ,Swiss ,Stephan Emmerth ,Dominik Escher ,Pureos Bioventures ,Rodrigo Vazquez Lombardi ,Novo Nordisk ,Partner At Novo Holdings ,Novo Group ,Novo Nordisk Foundation ,Novo Holdings To Engimmune ,Novo Holdings ,Engimmune Therapeutics ,Switzerlandi May ,Prof Sai Reddy ,Chief Scientific ,Enovo Seeds ,Board Directors ,Ximing Ding ,Chief Executive Officer ,Managing Partner ,Biologics ,Na ,Gene Therapy ,Dirna ,Unai ,Antisense ,Oligonucleotides ,Cells ,Cell Therapy ,Stem Cells ,